Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/40150
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorRestrepo Gutiérrez, Juan Carlos-
dc.contributor.authorCamacho Domínguez, Laura-
dc.contributor.authorRodríguez, Yhojan-
dc.contributor.authorPolo, Fernando-
dc.contributor.authorRojas, Manuel-
dc.contributor.authorAnaya Cabrera, Juan Manuel-
dc.date.accessioned2024-06-19T20:51:52Z-
dc.date.available2024-06-19T20:51:52Z-
dc.date.issued2022-
dc.identifier.issn2589-9090-
dc.identifier.urihttps://hdl.handle.net/10495/40150-
dc.description.abstractABSTRACT: Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly remitted after the instauration of immunomodulatory management. This case, together with a comprehensive review of the literature, illustrates the association between COVID-19 vaccines and the development of autoimmune conditions.spa
dc.format.extent9 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleCOVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literaturespa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Gastrohepatologíaspa
dc.identifier.doi10.1016/j.jtauto.2022.100140-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2589-9090-
oaire.citationtitleJournal of translational autoimmunityspa
oaire.citationstartpage1spa
oaire.citationendpage9spa
oaire.citationvolume5spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeÁmsterdam, Países Bajosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTREVspa
dc.type.localArtículo de revisiónspa
dc.subject.decsHepatitis Autoinmune-
dc.subject.decsHepatitis, Autoimmune-
dc.subject.decsCOVID-19-
dc.subject.decsSARS-CoV-2-
dc.subject.decsChAdOx1 nCoV-19-
dc.subject.proposalAstraZenecaspa
dc.subject.proposalAZD1222spa
dc.description.researchgroupidCOL0024159spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D019693-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000086382-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000086402-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000090985-
dc.relation.ispartofjournalabbrevJ. Transl. Autoimmun.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
RestrepoJuan_2022_COVID19_Vaccine_AutoimmuneHepatitis.pdfArtículo de revisión3.05 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons